ENvue Medical Statistics
Total Valuation
ENvue Medical has a market cap or net worth of $4.41 million. The enterprise value is $674,993.
| Market Cap | 4.41M |
| Enterprise Value | 674,993 |
Important Dates
The next estimated earnings date is Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENvue Medical has 1.09 million shares outstanding. The number of shares has decreased by -15.01% in one year.
| Current Share Class | 1.09M |
| Shares Outstanding | 1.09M |
| Shares Change (YoY) | -15.01% |
| Shares Change (QoQ) | +77.16% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 1.00% |
| Float | 1.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | 0.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.07.
| Current Ratio | 0.86 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.44 |
Financial Efficiency
Return on equity (ROE) is -30.51% and return on invested capital (ROIC) is -24.79%.
| Return on Equity (ROE) | -30.51% |
| Return on Assets (ROA) | -19.99% |
| Return on Invested Capital (ROIC) | -24.79% |
| Return on Capital Employed (ROCE) | -22.10% |
| Revenue Per Employee | $86,613 |
| Profits Per Employee | -$147,839 |
| Employee Count | 31 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.84 |
Taxes
In the past 12 months, ENvue Medical has paid $117,000 in taxes.
| Income Tax | 117,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.67% in the last 52 weeks. The beta is 2.06, so ENvue Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | -93.67% |
| 50-Day Moving Average | 5.08 |
| 200-Day Moving Average | 16.97 |
| Relative Strength Index (RSI) | 45.35 |
| Average Volume (20 Days) | 32,485 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ENvue Medical had revenue of $2.69 million and -$4.58 million in losses. Loss per share was -$25.93.
| Revenue | 2.69M |
| Gross Profit | 806,000 |
| Operating Income | -9.45M |
| Pretax Income | -6.65M |
| Net Income | -4.58M |
| EBITDA | -8.81M |
| EBIT | -9.45M |
| Loss Per Share | -$25.93 |
Full Income StatementBalance Sheet
The company has $6.95 million in cash and $3.17 million in debt, giving a net cash position of $3.78 million or $3.47 per share.
| Cash & Cash Equivalents | 6.95M |
| Total Debt | 3.17M |
| Net Cash | 3.78M |
| Net Cash Per Share | $3.47 |
| Equity (Book Value) | 42.46M |
| Book Value Per Share | 42.00 |
| Working Capital | -1.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.24 million and capital expenditures -$37,000, giving a free cash flow of -$7.28 million.
| Operating Cash Flow | -7.24M |
| Capital Expenditures | -37,000 |
| Free Cash Flow | -7.28M |
| FCF Per Share | -$6.69 |
Full Cash Flow StatementMargins
Gross margin is 30.02%, with operating and profit margins of -351.77% and -251.92%.
| Gross Margin | 30.02% |
| Operating Margin | -351.77% |
| Pretax Margin | -247.56% |
| Profit Margin | -251.92% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENvue Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 15.01% |
| Shareholder Yield | 15.01% |
| Earnings Yield | -102.87% |
| FCF Yield | -163.43% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 12, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Aug 12, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ENvue Medical has an Altman Z-Score of -2.39. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.39 |
| Piotroski F-Score | n/a |
